Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Rica Howarth

Physician Assistant, Medical Monaca, PA Physician Assistant

NPI 1952530503 CMS profile 361621

3452 Brodhead Rd, Hemlock Building, Monaca, PA 15061

Open in the dashboard

General payments

$10,410

81 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rica Howarth of Monaca, PA is reported in the CMS Open Payments database as having received $10,410 across 81 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $719 8
2023 General $7,300 25
2022 General $1,411 30
2021 General $979 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rica Howarth
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Rica Howarth were reported at $719. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Rica Howarth Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $979 $156 $41–$563 $132
2022 $1,411 $185 $55–$649 $149
2023 $7,300 $199 $58–$717 $160
2024 $0 $206 $62–$740 $164
2025 $719 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $5,548 19 payments
  2. SK Life Science, Inc. $2,348 9 payments
  3. EMD Serono, Inc. $861 13 payments
  4. Biogen, Inc. $506 4 payments
  5. LivaNova USA, Inc. $161 4 payments
  6. Novartis Pharmaceuticals Corporation $130 4 payments
  7. Lundbeck LLC $124 1 payment
  8. Geron Corporation $123 1 payment
  9. Biohaven Pharmaceutical Holding Company Ltd. $123 15 payments
  10. Merck Sharp & Dohme Corporation $107 1 payment
  11. Other $380 10 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,894 6 payments
  2. Food and Beverage $2,907 63 payments
  3. Honoraria $1,400 4 payments
  4. Consulting Fee $1,000 3 payments
  5. Education $210 5 payments
Products named General payments · program years 2021–2025
  1. UBRELVY $5,452 15 payments
  2. QULIPTA $5,234 11 payments
  3. XCOPRI $2,278 7 payments
  4. TYSABRI $421 3 payments
  5. Mavenclad $347 3 payments
  6. NURTEC ODT Primary Care $148 17 payments
  7. VYEPTI $124 1 payment
  8. RYTELO $123 1 payment
  9. KEYTRUDA $107 1 payment
  10. NURTEC ODT Pain $106 2 payments
  11. Other $521 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

390

Median for Physician Assistant: 241

Drug cost

$25,304

Median for Physician Assistant: $4,110

Branded share of claims

20%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Lacosamide Generic 37 $8,255
Levetiracetam Generic 76 $3,124
Tiagabine Hcl Generic 12 $2,519
Clobazam Generic 12 $2,477
Dilantin Phenytoin Sodium Extended Brand 14 $2,342
Carbamazepine Er Carbamazepine Brand 15 $1,467
Carbidopa-Levodopa Carbidopa/Levodopa Brand 49 $1,380
Sumatriptan Succinate Generic 22 $1,103
Gabapentin Generic 26 $667
Lamotrigine Generic 42 $645

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Records

81 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record